Leveraging the species barrier to advance cancer therapy.

Publication Type:

Journal Article


Nature genetics, Volume 45, Issue 7, p.718-20 (2013)


2013, Center-Authored Paper, Clinical Research Division, Human Biology Division, July 2013


The discovery of new therapeutic targets and the personalization of treatments are two active areas of cancer research. New studies suggest that a 'co-clinical' approach may expedite both therapeutic target validation and risk stratification in patients with advanced prostate cancer.